Please choose between the following three options for navigation.
Do you know how Canada's Anti-Spam Legislation (CASL) will affect your business or not-for-profit organization? Find out what you need to do to comply and avoid liability and large monetary penalties.
As of July 1, 2014, CASL applies to businesses and not-for-profit organizations carrying out electronic communications in the course of their activities. CASL requires express or implied consent from the recipient to receive your "commercial electronic messages." Consent must also be obtained for software downloads as of January 15, 2015.
CASL imposes personal liability on officers and directors and vicarious liability on entities for acts of employees and agents. Failure to comply with CASL could result in administrative monetary penalties of up to $10 million per violation for corporations and up to $1 million per violation for individuals. The private right of action arises as of July 1, 2017.
Learn what you need to do to ensure your organization complies with the new CASL in Canada's Anti-Spam Legislation (CASL) — It's Here and It's Not Just Spam!, part of our Director's Source Webinar Series. Two lawyers with expertise in corporate-commercial affairs and not-for-profit organizations take you through the essentials.
Additional options and pricing may be available. See pricing and registration for more details.
Member Development and Support
It’s said that a crisis brings out the best in people and, in most cases, that’s true. But there is a dark side to tough times, as fraudsters prey on people who are uncertain and looking for easy answers.
March 18, 2020
The federal government’s actions and fiscal support to address the widespread and devastating economic fallout of the COVID-19 pandemic are welcomed by Chartered Professional Accountants of Canada (CPA Canada).
Listen to this special edition Practitioner’s Pulse webinar where we answer some frequently asked questions around practice management issues and some key financial reporting and auditing implications of COVID-19.